ARO BIOTHERAPEUTICS Trademark

Trademark Overview

On Thursday, August 9, 2018, a trademark application was filed for ARO BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ARO BIOTHERAPEUTICS trademark a serial number of 88982748. The federal status of this trademark filing is REGISTERED as of Tuesday, October 19, 2021. This trademark is owned by Aro Biotherapeutics Company. The ARO BIOTHERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biopharmaceutical fields, namely, development of pharmaceuticals for the treatment of diseases with high morbidity and mortality rates
aro biotherapeutics

General Information

Serial Number88982748
Word MarkARO BIOTHERAPEUTICS
Filing DateThursday, August 9, 2018
Status700 - REGISTERED
Status DateTuesday, October 19, 2021
Registration Number6531772
Registration DateTuesday, October 19, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2019

Trademark Statements

Disclaimer with Predetermined Text"BIOTHERAPEUTICS"
Goods and ServicesResearch and development in the pharmaceutical and biopharmaceutical fields, namely, development of pharmaceuticals for the treatment of diseases with high morbidity and mortality rates

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 16, 2018
Primary Code042
First Use Anywhere DateMonday, December 17, 2018
First Use In Commerce DateMonday, December 17, 2018

Trademark Owner History

Party NameAro Biotherapeutics Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19106
Party NameAro Biotherapeutics Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19146
Party NameAro Biotherapeutics Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19146

Trademark Events

Event DateEvent Description
Sunday, May 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, May 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, May 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, May 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, May 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 19, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, September 15, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 14, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, August 6, 2021USE AMENDMENT FILED
Monday, August 23, 2021DIVISIONAL PROCESSING COMPLETE
Friday, August 6, 2021DIVISIONAL REQUEST RECEIVED
Monday, August 23, 2021SOU EXTENSION 4 GRANTED
Friday, August 6, 2021SOU EXTENSION 4 FILED
Friday, August 6, 2021TEAS REQUEST TO DIVIDE RECEIVED
Friday, August 6, 2021TEAS EXTENSION RECEIVED
Friday, August 6, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 8, 2021SOU EXTENSION 3 GRANTED
Monday, February 8, 2021SOU EXTENSION 3 FILED
Monday, February 8, 2021TEAS EXTENSION RECEIVED
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020SOU EXTENSION 2 GRANTED
Thursday, August 6, 2020SOU EXTENSION 2 FILED
Tuesday, August 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 6, 2020TEAS EXTENSION RECEIVED
Saturday, February 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2020SOU EXTENSION 1 GRANTED
Thursday, February 6, 2020SOU EXTENSION 1 FILED
Thursday, February 6, 2020TEAS EXTENSION RECEIVED
Tuesday, August 6, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2019ASSIGNED TO LIE
Thursday, April 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION WRITTEN
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Thursday, August 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 13, 2018NEW APPLICATION ENTERED

Related Keywords

biotherapeutics development high diseases morbidity mortality rates treatment pharmaceuticals pharmaceutical biopharmaceutical